The gastric mucosa in gastric cancer patients in a low-incidence area

Robert M. Genta, Marc Pusztaszeri

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

BACKGROUND AND AIMS: Atrophic gastritis, intestinal metaplasia, and pyloric metaplasia are frequent precursors of noncardial intestinal-type gastric adenocarcinoma in populations in which both gastric cancer and Helicobacter pylori infection are common. We hypothesized that such lesions would be less prevalent in European gastric cancer patients. METHODS: Slides from patients who underwent gastrectomy for adenocarcinoma between 1997 and 2004 were reviewed. Tumors were categorized as intestinal or diffuse; non-neoplastic mucosa was evaluated for gastritis, atrophy, intestinal metaplasia and pyloric metaplasia. RESULTS: We studied 81 patients: 48 Swiss (mean age 68.5 years); 17 Italians (mean age 67.8 years); and 16 Iberians (mean age 54.8 years; P<0.001). Twelve tumors were proximal (all intestinal type), 12 in the corpus (six intestinal-type), and 57 antral (30 intestinal type). Patients with diffuse cancers were younger than those with intestinal type (P<0.05). Nineteen patients (23.4%) had a normal stomach; 30% of T1 tumors and 90% of T4s arose in a normal stomach (P<0.02). H. pylori gastritis was found in 47 patients (58%); they did not differ in age, sex, national origin, cancer location or type from those without gastritis. Intestinal metaplasia correlated with H. pylori gastritis (P=0.002). Pyloric metaplasia was infrequent and limited to rare microfoci. CONCLUSIONS: A quarter of the patients had a normal stomach, and pyloric metaplasia was distinctly uncommon. Approaches to prevention and early detection of gastric cancer based on bioptic or serological demonstration of atrophy and metaplasia could overlook at least 25% of the people at risk in certain populations and may need to be adapted to local conditions.

Original languageEnglish (US)
Pages (from-to)1085-1093
Number of pages9
JournalEuropean Journal of Gastroenterology and Hepatology
Volume18
Issue number10
DOIs
StatePublished - Oct 2006

Fingerprint

Metaplasia
Gastric Mucosa
Stomach Neoplasms
Incidence
Gastritis
Stomach
Helicobacter pylori
Neoplasms
Atrophy
Adenocarcinoma
Atrophic Gastritis
Helicobacter Infections
Gastrectomy
Early Detection of Cancer
Population
Mucous Membrane

Keywords

  • Atrophic gastritis
  • Epidemiology
  • Gastric cancer
  • Helicobacter pylori
  • Pyloric metaplasia

ASJC Scopus subject areas

  • Gastroenterology

Cite this

The gastric mucosa in gastric cancer patients in a low-incidence area. / Genta, Robert M.; Pusztaszeri, Marc.

In: European Journal of Gastroenterology and Hepatology, Vol. 18, No. 10, 10.2006, p. 1085-1093.

Research output: Contribution to journalArticle

Genta, Robert M. ; Pusztaszeri, Marc. / The gastric mucosa in gastric cancer patients in a low-incidence area. In: European Journal of Gastroenterology and Hepatology. 2006 ; Vol. 18, No. 10. pp. 1085-1093.
@article{3147a7300a764e6381398301564fceca,
title = "The gastric mucosa in gastric cancer patients in a low-incidence area",
abstract = "BACKGROUND AND AIMS: Atrophic gastritis, intestinal metaplasia, and pyloric metaplasia are frequent precursors of noncardial intestinal-type gastric adenocarcinoma in populations in which both gastric cancer and Helicobacter pylori infection are common. We hypothesized that such lesions would be less prevalent in European gastric cancer patients. METHODS: Slides from patients who underwent gastrectomy for adenocarcinoma between 1997 and 2004 were reviewed. Tumors were categorized as intestinal or diffuse; non-neoplastic mucosa was evaluated for gastritis, atrophy, intestinal metaplasia and pyloric metaplasia. RESULTS: We studied 81 patients: 48 Swiss (mean age 68.5 years); 17 Italians (mean age 67.8 years); and 16 Iberians (mean age 54.8 years; P<0.001). Twelve tumors were proximal (all intestinal type), 12 in the corpus (six intestinal-type), and 57 antral (30 intestinal type). Patients with diffuse cancers were younger than those with intestinal type (P<0.05). Nineteen patients (23.4{\%}) had a normal stomach; 30{\%} of T1 tumors and 90{\%} of T4s arose in a normal stomach (P<0.02). H. pylori gastritis was found in 47 patients (58{\%}); they did not differ in age, sex, national origin, cancer location or type from those without gastritis. Intestinal metaplasia correlated with H. pylori gastritis (P=0.002). Pyloric metaplasia was infrequent and limited to rare microfoci. CONCLUSIONS: A quarter of the patients had a normal stomach, and pyloric metaplasia was distinctly uncommon. Approaches to prevention and early detection of gastric cancer based on bioptic or serological demonstration of atrophy and metaplasia could overlook at least 25{\%} of the people at risk in certain populations and may need to be adapted to local conditions.",
keywords = "Atrophic gastritis, Epidemiology, Gastric cancer, Helicobacter pylori, Pyloric metaplasia",
author = "Genta, {Robert M.} and Marc Pusztaszeri",
year = "2006",
month = "10",
doi = "10.1097/01.meg.0000231753.58211.05",
language = "English (US)",
volume = "18",
pages = "1085--1093",
journal = "European Journal of Gastroenterology and Hepatology",
issn = "0954-691X",
publisher = "Lippincott Williams and Wilkins",
number = "10",

}

TY - JOUR

T1 - The gastric mucosa in gastric cancer patients in a low-incidence area

AU - Genta, Robert M.

AU - Pusztaszeri, Marc

PY - 2006/10

Y1 - 2006/10

N2 - BACKGROUND AND AIMS: Atrophic gastritis, intestinal metaplasia, and pyloric metaplasia are frequent precursors of noncardial intestinal-type gastric adenocarcinoma in populations in which both gastric cancer and Helicobacter pylori infection are common. We hypothesized that such lesions would be less prevalent in European gastric cancer patients. METHODS: Slides from patients who underwent gastrectomy for adenocarcinoma between 1997 and 2004 were reviewed. Tumors were categorized as intestinal or diffuse; non-neoplastic mucosa was evaluated for gastritis, atrophy, intestinal metaplasia and pyloric metaplasia. RESULTS: We studied 81 patients: 48 Swiss (mean age 68.5 years); 17 Italians (mean age 67.8 years); and 16 Iberians (mean age 54.8 years; P<0.001). Twelve tumors were proximal (all intestinal type), 12 in the corpus (six intestinal-type), and 57 antral (30 intestinal type). Patients with diffuse cancers were younger than those with intestinal type (P<0.05). Nineteen patients (23.4%) had a normal stomach; 30% of T1 tumors and 90% of T4s arose in a normal stomach (P<0.02). H. pylori gastritis was found in 47 patients (58%); they did not differ in age, sex, national origin, cancer location or type from those without gastritis. Intestinal metaplasia correlated with H. pylori gastritis (P=0.002). Pyloric metaplasia was infrequent and limited to rare microfoci. CONCLUSIONS: A quarter of the patients had a normal stomach, and pyloric metaplasia was distinctly uncommon. Approaches to prevention and early detection of gastric cancer based on bioptic or serological demonstration of atrophy and metaplasia could overlook at least 25% of the people at risk in certain populations and may need to be adapted to local conditions.

AB - BACKGROUND AND AIMS: Atrophic gastritis, intestinal metaplasia, and pyloric metaplasia are frequent precursors of noncardial intestinal-type gastric adenocarcinoma in populations in which both gastric cancer and Helicobacter pylori infection are common. We hypothesized that such lesions would be less prevalent in European gastric cancer patients. METHODS: Slides from patients who underwent gastrectomy for adenocarcinoma between 1997 and 2004 were reviewed. Tumors were categorized as intestinal or diffuse; non-neoplastic mucosa was evaluated for gastritis, atrophy, intestinal metaplasia and pyloric metaplasia. RESULTS: We studied 81 patients: 48 Swiss (mean age 68.5 years); 17 Italians (mean age 67.8 years); and 16 Iberians (mean age 54.8 years; P<0.001). Twelve tumors were proximal (all intestinal type), 12 in the corpus (six intestinal-type), and 57 antral (30 intestinal type). Patients with diffuse cancers were younger than those with intestinal type (P<0.05). Nineteen patients (23.4%) had a normal stomach; 30% of T1 tumors and 90% of T4s arose in a normal stomach (P<0.02). H. pylori gastritis was found in 47 patients (58%); they did not differ in age, sex, national origin, cancer location or type from those without gastritis. Intestinal metaplasia correlated with H. pylori gastritis (P=0.002). Pyloric metaplasia was infrequent and limited to rare microfoci. CONCLUSIONS: A quarter of the patients had a normal stomach, and pyloric metaplasia was distinctly uncommon. Approaches to prevention and early detection of gastric cancer based on bioptic or serological demonstration of atrophy and metaplasia could overlook at least 25% of the people at risk in certain populations and may need to be adapted to local conditions.

KW - Atrophic gastritis

KW - Epidemiology

KW - Gastric cancer

KW - Helicobacter pylori

KW - Pyloric metaplasia

UR - http://www.scopus.com/inward/record.url?scp=33748628873&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33748628873&partnerID=8YFLogxK

U2 - 10.1097/01.meg.0000231753.58211.05

DO - 10.1097/01.meg.0000231753.58211.05

M3 - Article

C2 - 16957515

AN - SCOPUS:33748628873

VL - 18

SP - 1085

EP - 1093

JO - European Journal of Gastroenterology and Hepatology

JF - European Journal of Gastroenterology and Hepatology

SN - 0954-691X

IS - 10

ER -